New research has shown fingolimod 0.5mg, a first-line treatment for multiple sclerosis (MS), reduces both the number of relapses and disease progression in patients with relapsing-remitting MS and
The ‘ideal’ syringe for administering intravitreal injections may be available as early as next year, and there are several key factors syringe manufacturers should focus on to improve safety
New Zealand optometrist and contact lens specialist Jagrut Lallu has developed a new cloud-based dry eye tool to help advance research and support clinician’s dry eye treatment assessments and patient management.
Hamilton-based ophthalmologist and Auckland University senior lecturer Dr James McKelvie is leading the charge, together with several of his ophthalmology colleagues, to combat the postcode disparity for cataract surgery and obtain better eye care for all in New Zealand.
The Public Service Association (PSA) and District Health Boards (DHBs) have announced an initial agreement for pay equity for clerical and administration staff. The initial agreement between DHBs and
After a tumultuous year, Ophthalmology New Zealand (ONZ) finally held its 2020 Business Forum, The Other Matters, at Villa Maria Estate in Auckland in October.
Socio-environmental factors impact the performance of artificial intelligence (AI) screening models used to detect eye disease and should be considered when evaluating model accuracy, a recently published Google Health paper has revealed.
Well-known ophthalmologist and New Zealand refractive surgery pioneer Dr Tony Morris was remembered by family, friends and colleagues at a memorial service in Auckland in October.
On October 13, Jasha Morarji died peacefully at the Mercy Hospice after a long, two-and-a-half-year battle with cancer. Typically, Jasha fought this all the way, enduring two major operations and countless bouts of chemotherapy.
Eye health won big in this year’s edition of the Spark 5G Starter Fund challenge, with oDocs Eye Care and Objective Acuity securing a share of $625,000 alongside two other innovative New Zealand businesses.
Featuring top-notch speakers from Korea and around the world, the Asia Pacific Tele-Ophthalmology Society (APTOS) 2020 online, one-day conference on 12 December will showcase clinical applications of artificial intelligence (AI) in telemedicine and teleophthalmology’s role in bringing together physi
Australian biopharmaceutical company PolyActiva announced it has successfully completed its Phase I clinical study on its lead glaucoma treatment candidate, the Latanoprost FA SR Ocular Implant. The
